nash semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers Phase 3 Trial of Semaglutide

together with the weight loss itself, this helps manage inflammation (reduction in pro-inflammatory cytokines), improves the lipid profile and the endothelial function, and indirectly reduces the risk of complications (including the particularly common cardiovascular incidents) in patients with type 2 diabetes

Ozempic (semaglutide), a GLP-1 receptor agonist developed by Novo Nordisk, is a cornerstone treatment for type 2 diabetes and is increasingly prescribed for weight management

And this wasnt even This was studies from all over the world

During perimenopause, estrogen and other hormones shift irregularly, which can make healthy routines feel less effective

This can sometimes lead to hypoglycemia (low blood sugar)